LH vs. SOLV: Labcorp vs. Solventum Stock Comparison
How do Labcorp (LH) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Labcorp (LH) and Solventum (SOLV) both fall under the Health Care Equipment & Services industry group, but LH is classified in Health Care Providers & Services while SOLV is classified in Health Care Equipment & Supplies.
Labcorp (LH) carries decades of public-market history since March 29, 1990, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the LH side.
| Profile Item | LH | SOLV |
|---|---|---|
| Name | Labcorp Holdings Inc. | Solventum Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Supplies |
| Market Capitalization | 29.77 billion USD | 15.36 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 29, 1990 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | LH | SOLV |
|---|---|---|
| Total Return (1Y) | 48.62% | 25.89% |
| Total Return (3Y, Annualized) | 23.39% | -- |
| Total Return (5Y, Annualized) | 10.54% | -- |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | LH | SOLV |
|---|---|---|
| Volatility (1Y, Annualized) | 24.36% | 30.06% |
| Beta (5Y) | 0.85 | 0.62 |
| Max Drawdown (5Y) | -34.61% | -39.98% |
| Avg. Volume (3M) | 721.05K | 1.05M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | LH | SOLV |
|---|---|---|
| Sharpe Ratio (1Y) | 1.82 | 0.72 |
| Sortino Ratio (1Y) | 2.99 | 1.08 |
Profitability
ROE (TTM)
Both Labcorp (LH) at 11.44% and Solventum (SOLV) at 3.19% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
LH
Health Care Equipment & Services industry group
11.44%
- Max
- 47.61%
- Q3
- 14.36%
- LH
- 11.44%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
SOLV
Health Care Equipment & Services industry group
3.19%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- SOLV
- 3.19%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Both Labcorp (LH) at 6.88% and Solventum (SOLV) at 1.91% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.
LH
Health Care Equipment & Services industry group
6.88%
- Max
- 29.35%
- Q3
- 9.33%
- LH
- 6.88%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
SOLV
Health Care Equipment & Services industry group
1.91%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- SOLV
- 1.91%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Labcorp (LH) at 10.91% and Solventum (SOLV) at 6.82% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.
LH
Health Care Equipment & Services industry group
10.91%
- Max
- 35.43%
- Q3
- 14.14%
- LH
- 10.91%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
SOLV
Health Care Equipment & Services industry group
6.82%
- Max
- 35.43%
- Q3
- 14.14%
- SOLV
- 6.82%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | LH | SOLV |
|---|---|---|
| ROE (TTM) | 11.44% | 3.19% |
| ROA (TTM) | 5.48% | 2.29% |
| Net Margin (TTM) | 6.88% | 1.91% |
| Operating Margin (TTM) | 10.91% | 6.82% |
| Gross Margin (TTM) | 28.96% | 55.13% |
Growth
Revenue Growth
Labcorp (LH) at 7.25% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.
EPS Growth
Solventum (SOLV) at 221.74% clears its industry range for EPS growth, a much stronger earnings trajectory than Labcorp (LH) at 18.33%, which is closer to a typical peer reading.
Growth Metrics
| Metric | LH | SOLV |
|---|---|---|
| Revenue Growth (YoY) | 7.25% | 0.86% |
| Revenue Growth (3Y CAGR) | 5.55% | 0.79% |
| EPS Growth (YoY) | 18.33% | 221.74% |
| EPS Growth (3Y CAGR) | -9.19% | 4.51% |
Financial Strength
Current Ratio (MRQ)
Labcorp (LH) at 1.41 keeps current ratio within its industry’s typical mid-range, while Solventum (SOLV) at 1.03 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for SOLV.
LH
Health Care Equipment & Services industry group
1.41
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- LH
- 1.41
- Q1
- 1.37
- Min
- 0.30
SOLV
Health Care Equipment & Services industry group
1.03
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- SOLV
- 1.03
- Min
- 0.30
Debt / Equity (MRQ)
Labcorp (LH) at 0.77 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.
LH
Health Care Equipment & Services industry group
0.77
- Max
- 1.88
- Q3
- 0.91
- LH
- 0.77
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
SOLV
Health Care Equipment & Services industry group
1.10
- Max
- 1.88
- SOLV
- 1.10
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | LH | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 1.41 | 1.03 |
| Debt / Equity (MRQ) | 0.77 | 1.10 |
| Net Debt / EBITDA | 2.81 | 4.66 |
Dividends
Dividend Yield (TTM)
Solventum (SOLV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Labcorp (LH) reports a yield of 0.79%, ranking against industry peers normally.
LH
Health Care Equipment & Services industry group
0.79%
- LH
- 0.79%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Solventum (SOLV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Labcorp (LH) reports a payout of 23.61%, ranking against industry peers normally.
LH
Health Care Equipment & Services industry group
23.61%
- LH
- 23.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | LH | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 0.79% | 0.00% |
| Dividend Payout Ratio (TTM) | 23.61% | 0.00% |
Valuation
P/E Ratio (TTM)
Labcorp (LH) at 30.05 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.
LH
Health Care Equipment & Services industry group
30.05
- Max
- 80.41
- Q3
- 47.62
- LH
- 30.05
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
SOLV
Health Care Equipment & Services industry group
101.55
- SOLV
- 101.55
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Labcorp (LH) at 2.04 and Solventum (SOLV) at 1.88 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
LH
Health Care Equipment & Services industry group
2.04
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- LH
- 2.04
- Q1
- 1.10
- Min
- 0.03
SOLV
Health Care Equipment & Services industry group
1.88
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- SOLV
- 1.88
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Labcorp (LH) at 3.36 and Solventum (SOLV) at 3.20 are valued close to their industries’ norm against book — neither stands out from peers.
LH
Health Care Equipment & Services industry group
3.36
- Max
- 11.68
- Q3
- 6.12
- LH
- 3.36
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
SOLV
Health Care Equipment & Services industry group
3.20
- Max
- 11.68
- Q3
- 6.12
- SOLV
- 3.20
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | LH | SOLV |
|---|---|---|
| P/E Ratio (TTM) | 30.05 | 101.55 |
| P/S Ratio (TTM) | 2.04 | 1.88 |
| P/B Ratio (MRQ) | 3.36 | 3.20 |
| Free Cash Flow Yield (TTM) | 3.55% | 1.31% |